Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification

被引:12
作者
Kaczmarek, Elzbieta [1 ]
Lacka, Katarzyna [2 ]
Majewski, Przemyslaw [1 ]
Trzeciak, Pawel [1 ]
Gorna, Agnieszka [1 ]
Jarmolowska-Jurczyszyn, Donata [1 ]
Kluk, Andrzej [1 ]
机构
[1] Karol Marcinkowski Univ Med Sci, Dept Pathomorphol, PL-60355 Poznan, Poland
[2] Karol Marcinkowski Univ Med Sci, Dept Endocrinol, PL-60355 Poznan, Poland
关键词
hyperparathyroidism; PCNA; Ki-67; Bcl-2; image analysis; morphometry;
D O I
10.1007/s10735-008-9190-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The aim of the paper was to apply a method for quantitative assessment of proliferation and apoptosis markers, based on their 3D visualization, in cases of parathyroid adenoma and hyperplasia. Material was obtained from 49 patients (32 females and 17 males) with primary hyperparahyroidism. Quantitative immunohistochemistry studies of Ki-67, proliferating cell nuclear antigen (PCNA) and bcl-2 were performed on digital microscopy images with the use of 3D visualization. The use of spatial visualization method allowed us to perform objective quantitative assessment of the studied immunohistochemical markers. The average cell nuclear fraction of Ki67+ was 1.8% in hyperplasia and 1.9% in adenoma cases while 3.5% in the controls. The highest expression of PCNA was found in parathyroid hyperplasia (22.9%) and significantly decreased in adenoma (12.5%) and in the control group (16.8%). The lower expression of bcl-2 in hyperplasia cases (mean area fraction of 0.172 per 1 mu m(2), in contrast to 0.643 in adenomas and 0.648 in control) suggested that principal cells can be ready for apoptosis and may confirm the important role of bcl-2 protein in etiopathogenesis of hyperplasia of the parathyroid gland while PCNA might be a useful marker for differentiating adenoma from early hyperplasia in primary hyperparahyroidism cases.
引用
收藏
页码:509 / 517
页数:9
相关论文
共 25 条
[1]   PROLIFERATIVE ACTIVITY IN PARATHYROID TUMORS AS DETECTED BY KI-67 IMMUNOSTAINING [J].
ABBONA, GC ;
PAPOTTI, M ;
GASPARRI, G ;
BUSSOLATI, G .
HUMAN PATHOLOGY, 1995, 26 (02) :135-138
[2]  
Alo P L, 1999, Ann Diagn Pathol, V3, P287, DOI 10.1016/S1092-9134(99)80024-0
[3]  
[Anonymous], WHO CLASSIFICATION T
[4]   Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[5]   Genetics of primary hyperparathyroidism [J].
Brandi, ML ;
Falchetti, A .
UROLOGIA INTERNATIONALIS, 2004, 72 :11-16
[6]   Digital quantification of fibrosis in liver biopsy sections: Description of a new method by Photoshop software [J].
Dahab, GM ;
Kheriza, MM ;
El-Beltagi, HM ;
Fouda, AMM ;
El-Din, OAS .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (01) :78-85
[7]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[8]   NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model [J].
Diallo, Jean-Simon ;
Aldejmah, Abdulhadi ;
Mouhim, Abdelali Filali ;
Peant, Benjamin ;
Fahmy, Mona Alam ;
Koumakpayi, Ismaeel Herve ;
Sircar, Kanishka ;
Begin, Louis R. ;
Mes-Masson, Anne-Marie ;
Saad, Fred .
CLINICAL CANCER RESEARCH, 2007, 13 (23) :7044-7052
[9]   The Ki-67 protein: Fascinating forms and an unknown function [J].
Endl, E ;
Gerdes, J .
EXPERIMENTAL CELL RESEARCH, 2000, 257 (02) :231-237
[10]   Expression of p53, Ki-67 and bcl-2 in parathyroid adenoma and residual normal tissue [J].
Hadar, T ;
Shvero, J ;
Yaniv, E ;
Ram, E ;
Shvili, I ;
Koren, R .
PATHOLOGY & ONCOLOGY RESEARCH, 2005, 11 (01) :45-49